- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.51 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x W9Y: (1S,2S,3R,4S,5S)-1-(hydroxymethyl)-5-[(6-{[2-nitro-4-(1H-1,2,3-triazol-1-yl)phenyl]amino}hexyl)amino]cyclohexane-1,2,3,4-tetrol(Non-covalent)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 8 residues within 4Å:- Chain A: N.441, M.442, F.723, V.837, R.838, R.839
- Chain B: S.107, R.108
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:S.107, B:R.108, B:R.108, A:V.837
- Water bridges: A:M.442
EDO.3: 3 residues within 4Å:- Chain A: R.719, D.720, F.723
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.720, A:D.720
EDO.4: 4 residues within 4Å:- Chain A: A.478, S.479, R.481
- Chain B: G.112
1 PLIP interactions:1 interactions with chain A- Water bridges: A:A.478
EDO.5: 5 residues within 4Å:- Chain A: W.462, F.467, P.468, P.470, G.553
No protein-ligand interaction detected (PLIP)EDO.8: 5 residues within 4Å:- Chain A: Q.738, K.741, E.742, E.864, L.883
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Q.738, A:E.742, A:E.742, A:E.864
EDO.9: 6 residues within 4Å:- Chain A: F.731, T.734, I.830, P.832, G.863, E.864
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:T.734, A:T.734, A:E.864
EDO.11: 5 residues within 4Å:- Chain A: R.499, W.541, N.544, M.545, N.550
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.499, A:W.541
EDO.12: 2 residues within 4Å:- Chain A: T.892, H.963
No protein-ligand interaction detected (PLIP)EDO.13: 2 residues within 4Å:- Chain A: R.398, F.744
No protein-ligand interaction detected (PLIP)EDO.14: 3 residues within 4Å:- Chain A: R.505, S.517, D.518
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.505, A:D.518, A:D.518
- Water bridges: A:D.518, A:E.520
EDO.16: 3 residues within 4Å:- Chain A: H.179, R.181, A.182
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:A.182
EDO.18: 3 residues within 4Å:- Chain A: V.925, E.933, R.935
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.933, A:E.933
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 5 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.7: 7 residues within 4Å:- Chain A: V.894, S.895, Q.927, K.929, D.959, W.960, S.961
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.895
PEG.10: 4 residues within 4Å:- Chain A: S.955, A.957, S.958
- Ligands: SO4.26
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.958
PEG.15: 4 residues within 4Å:- Chain A: D.439, H.440, N.441, R.719
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.439, A:N.441
PEG.17: 3 residues within 4Å:- Chain A: S.762, E.764, D.765
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.762
PEG.19: 2 residues within 4Å:- Chain A: G.614, F.873
No protein-ligand interaction detected (PLIP)- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.21: 4 residues within 4Å:- Chain A: K.805, H.806, H.807, Q.810
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:H.807, A:H.807, A:Q.810
- Salt bridges: A:K.805
SO4.22: 2 residues within 4Å:- Chain A: R.425, R.466
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.466
SO4.23: 9 residues within 4Å:- Chain A: L.412, Y.733, W.834, K.845, F.866, L.867, D.868, D.869, G.870
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.868, A:D.868, A:D.868
SO4.24: 6 residues within 4Å:- Chain A: K.290, V.291, T.292, E.296, Y.298, P.313
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:V.291, A:E.296
SO4.25: 5 residues within 4Å:- Chain A: T.513, R.514, L.578, D.580, A.581
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.514, A:D.580
SO4.26: 6 residues within 4Å:- Chain A: L.904, E.905, T.906, S.955, A.957
- Ligands: PEG.10
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:L.904, A:T.906, A:S.955, A:S.955
SO4.27: 5 residues within 4Å:- Chain A: F.673, K.674, H.699, D.701, T.702
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.674
- Salt bridges: A:H.699
SO4.28: 2 residues within 4Å:- Chain A: K.674, N.675
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.675, A:N.675
- 2 x CA: CALCIUM ION(Non-covalent)
CA.29: 6 residues within 4Å:- Chain B: Q.67, D.70, Y.72, D.74, D.80, E.81
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:Q.67, B:D.70, B:Y.72, B:D.74, B:D.80, B:E.81
CA.30: 6 residues within 4Å:- Chain B: R.108, D.111, V.113, D.115, D.121, E.122
6 PLIP interactions:6 interactions with chain B- Metal complexes: B:R.108, B:D.111, B:V.113, B:D.115, B:D.121, B:E.122
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karade, S.S. et al., N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum alpha-Glucosidases I and II with Antiviral Activity. J.Med.Chem. (2021)
- Release Date
- 2021-10-06
- Peptides
- Isoform 2 of Neutral alpha-glucosidase AB: A
Glucosidase 2 subunit beta: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.51 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x W9Y: (1S,2S,3R,4S,5S)-1-(hydroxymethyl)-5-[(6-{[2-nitro-4-(1H-1,2,3-triazol-1-yl)phenyl]amino}hexyl)amino]cyclohexane-1,2,3,4-tetrol(Non-covalent)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 5 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Karade, S.S. et al., N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum alpha-Glucosidases I and II with Antiviral Activity. J.Med.Chem. (2021)
- Release Date
- 2021-10-06
- Peptides
- Isoform 2 of Neutral alpha-glucosidase AB: A
Glucosidase 2 subunit beta: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D